PTC Therapeutics Inc (STU:BH3)
€ 36.8 0 (0%) Market Cap: 2.89 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

PTC Therapeutics Inc CEO Appointment - Corporate Call Transcript

Mar 24, 2023 / 12:30PM GMT
Release Date Price: €40.4 (-4.72%)
Operator

Good day, and thank you for standing by. Welcome to the PTC Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Kylie O'Keefe, Chief Commercial Officer. Please go ahead.

Kylie O;Keefe
PTC Therapeutics, Inc. - Chief Commercial Officer

' -

Good afternoon, and thank you for joining our conference call today. I am joined by PTC's new Chief Executive Officer and President, Dr. Matthew Klein. As announced in a press release earlier this morning, Founding CEO, Stuart Peltz, has announced he is retiring after 25 incredible years of building and leading PTC. This transition is effective immediately. Today's call will include forward-looking statements based on our current expectations. Our actual results could materially differ from these forward-looking statements. As such, statements are subject to risks that can materially and adversely affect our business and results of operation. For a detailed description of applicable risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot